X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (243) 243
index medicus (219) 219
infectious diseases (190) 190
hiv infections - drug therapy (171) 171
antiretroviral-naive adults (148) 148
male (142) 142
adult (141) 141
female (136) 136
hiv (136) 136
once-daily dolutegravir (123) 123
pharmacology & pharmacy (111) 111
double-blind (109) 109
middle aged (105) 105
immunology (95) 95
raltegravir (87) 87
hiv infections - virology (85) 85
hiv-1 - drug effects (77) 77
anti-hiv agents - therapeutic use (73) 73
microbiology (73) 73
therapy (73) 73
virology (71) 71
antiretroviral-naive (68) 68
hiv infection (66) 66
dolutegravir (63) 63
tenofovir (61) 61
human immunodeficiency virus--hiv (57) 57
antiviral agents (51) 51
anti-hiv agents - adverse effects (50) 50
drug therapy (49) 49
antiretroviral drugs (48) 48
antiretroviral therapy (48) 48
antiretroviral-naive patients (48) 48
treatment outcome (48) 48
hiv-1 - genetics (47) 47
viral load (46) 46
infection (45) 45
aids/hiv (44) 44
safety (44) 44
anti-hiv agents - administration & dosage (43) 43
mutation (43) 43
young adult (43) 43
pharmacokinetics (42) 42
drug resistance, viral (41) 41
hiv-1 infection (40) 40
drug resistance (39) 39
cd4 lymphocyte count (38) 38
hiv-1 (38) 38
emtricitabine (37) 37
lamivudine (37) 37
adolescent (36) 36
aids (36) 36
efficacy (36) 36
initial treatment (36) 36
analysis (35) 35
heterocyclic compounds, 3-ring - therapeutic use (35) 35
hiv integrase inhibitors - therapeutic use (35) 35
non-inferiority trial (35) 35
protease inhibitors (35) 35
research (35) 35
efavirenz (34) 34
tenofovir disoproxil fumarate (32) 32
highly active antiretroviral therapy (31) 31
prevalence (31) 31
resistance (31) 31
hiv-1-infected patients (30) 30
open-label (30) 30
adenine - analogs & derivatives (29) 29
hiv integrase inhibitors - pharmacology (29) 29
aged (28) 28
drug resistance, viral - genetics (28) 28
heterocyclic compounds, 3-ring - administration & dosage (28) 28
heterocyclic compounds, 3-ring - adverse effects (28) 28
integrase (28) 28
patients (28) 28
risk factors (28) 28
anti-hiv agents - pharmacology (27) 27
antiretroviral agents (27) 27
clinical trials (27) 27
co-formulated elvitegravir (27) 27
health aspects (27) 27
heterocyclic compounds, 3-ring - pharmacology (27) 27
drug therapy, combination (26) 26
hiv-infected patients (25) 25
human-immunodeficiency-virus (25) 25
abacavir (24) 24
acquired immune deficiency syndrome--aids (24) 24
care and treatment (24) 24
drug-resistance (24) 24
elvitegravir (24) 24
hiv infections - epidemiology (24) 24
antiretroviral naive (23) 23
dosage and administration (23) 23
genotype (23) 23
lamivudine - therapeutic use (23) 23
reverse transcriptase inhibitors - therapeutic use (23) 23
ritonavir (23) 23
drug interactions (22) 22
hiv-1 - isolation & purification (22) 22
human immunodeficiency virus (22) 22
medical research (22) 22
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, ISSN 1525-4135, 06/2017, Volume 75, Issue 2, pp. 226 - 231
In a double-blind, phase 3 trial, 663 HIV-infected, virologically suppressed adults were randomized to switch to tenofovir alafenamide (TAF; n = 333) vs.... 
osteopenia | ANTIRETROVIRAL-NAIVE | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | ELVITEGRAVIR | proteinuria | COBICISTAT | EMTRICITABINE | IMMUNOLOGY | DENSITY | HIV | EFAVIRENZ | DOUBLE-BLIND | ABACAVIR/LAMIVUDINE | tenofovir alafenamide | TENOFOVIR/EMTRICITABINE
Journal Article
by Winston, A and Stöhr, W and Antinori, A and Arenas-Pinto, A and Llibre, J. M and Amieva, H and Cabié, A and Williams, I and Di Perri, G and Tellez, M. J and Rockstroh, J and Babiker, A and Pozniak, A and Raffi, F and Richert, L and Dedes, Nikos and Chene, Genevieve and Allavena, Clotilde and Autran, Brigitte and Bucciardini, Raffaella and Vella, Stefano and Horban, Anzej and Arribas, Jose and Boffito, Marta and Pillay, Deenan and Franquet, Xavier and Schwarze, Siegfried and Grarup, Jesper and Fischer, Aurelie and Wallet, Ceick and Diallo, Alpha and Molina, Jean-Michel and Saillard, Juliette and Moecklinghoff, Christiane and Stellbrink, Hans-Jurgen and Leeuwen, Remko and Gatell, Jose and Sandstrom, Eric and Flepp, Markus and Ewings, Fiona and George, Elizabeth C and Hudson, Fleur and Pearce, Gillian and Quercia, Romina and Rogatto, Felipe and Leavitt, Randi and Nguyen, Bach-Yen and Goebel, Frank and Marcotullio, Simone and Kaur, Navrup and Sasieni, Peter and Spencer-ke, Christina and Peto, Tim and Miller, Veronica and Chêne, Geneviève and Arnault, Fabien and Boucherie, Céline and Fischer, Aurélie and Jean, Delphine and Paniego, Virginie and Rouch, Elodie and Schwimmer, Christine and Soussi, Malika and Taieb, Auey and Termote, Monique and Touzeau, Guillaume and Wallet, Céick and Cursley, Adam and Dodds, Wendy and Hoppe, Anne and Kummeling, Ischa and Pacciarini, Filippo and Paton, Nick and Russell, Charlotte and Taylor, Kay and Ward, Denise and Aagaard, Bitten and Eid, Marius and Gey, Daniela and Jensen, Birgitte and Jakobsen, Marie-Louise and Jansson, Per O and Jensen, Karoline and Joensen, Zillah and Larsen, Ellen and Pahl, Christiane and Pearson, Mary and Nielsen, Birgit and Reilev, Søren and Christ, Ilse and Lathouwers, Desiree and Manting, Corry and Mendy, Bienvenu and Metro, Annie and Couffin-Cadiergues, Sanine and Knellwolf, Anne-Laure and Palmisiano, Lucia and Aznar, Esther and Barea, Cristina and Cotarelo, Manuel and ... and NEAT 001 Agence Natl Rech Sur SIDA and NEAT 001/Agence Nationale de Recherche sur le SIDA (ANRS) 143 Study Group and the NEAT 001/Agence Nationale de Recherche sur le SIDA (ANRS) 143 Study Group and Paediatrics (Lund) and Lund University and Lunds universitet and Pediatrik, Lund
HIV medicine, ISSN 1464-2662, 2016, Volume 17, Issue 6, pp. 471 - 478
Journal Article
Journal Article
Clinical Microbiology Reviews, ISSN 0893-8512, 07/2016, Volume 29, Issue 3, pp. 695 - 747
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 19, pp. 1807 - 1818
Journal Article
AIDS, ISSN 0269-9370, 01/2001, Volume 15, Issue 1, pp. F1 - F9
Objective: To evaluate the safety and antiviral activity of different dose levels of the HIV protease inhibitor ABT-378 combined with low-dose ritonavir, plus... 
Antiretroviral-naive | ABT-378 | Phase II clinical study | ABT-378/r | Protease inhibitor | INDINAVIR | phase II clinical study | INFECTIOUS DISEASES | protease inhibitor | CONTROLLED TRIAL | antiretroviral-naive | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | THERAPY | VIROLOGY | ZIDOVUDINE | RESISTANCE | INHIBITOR | PROTEASE | RITONAVIR | Humans | Male | RNA, Viral - blood | Viral Load | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | HIV Infections - immunology | Reverse Transcriptase Inhibitors - pharmacokinetics | Ritonavir - adverse effects | Stavudine - adverse effects | HIV Protease Inhibitors - pharmacokinetics | Stavudine - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | HIV Protease Inhibitors - adverse effects | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Lopinavir | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | CD4 Lymphocyte Count | Lamivudine - pharmacokinetics | HIV Protease Inhibitors - therapeutic use | Pyrimidinones - pharmacokinetics | Ritonavir - pharmacokinetics | Anti-HIV Agents - pharmacokinetics | HIV Infections - drug therapy | HIV Infections - physiopathology | Stavudine - pharmacokinetics
Journal Article
AIDS, ISSN 0269-9370, 08/2017, Volume 31, Issue 13, pp. 1853 - 1858
Journal Article